Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trialYuzhou Zhao, Ying Liu, Zhi Li et al.|Clinical and Translational Medicine|2024Cited by 22
A HYBRID ENERGY‐ AND AI‐BASED SCREENING FOR NOVEL INHIBITORS OF LCK FOR THE TREATMENT OF T‐CELL LYMPHOBLASTIC LYMPHOMAHang Guo, Keshu Zhou, Huili Wang et al.|Hematological Oncology|2023Cited by 0
495P Safety and efficacy of nab-sirolimus (HB1901) + endocrine therapy in HR+/HER2- advanced breast cancer after standard therapy failure: A multicenter, open-label, phase 2 studyFei Ma, Hongnan Mo, Jie Cui et al.|Annals of Oncology|2025Cited by 0